1,061 results on '"Hughes, Dyfrig"'
Search Results
2. A proposal for using benefit-risk methods to improve the prominence of adverse event results when reporting trials
3. Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
4. Developing an alternative care pathway for emergency ambulance responses for adults with epilepsy: A Discrete Choice Experiment to understand which configuration service users prefer. Part of the COLLABORATE project
5. Service users' preferences and feasibility – which alternative care pathway for adult ambulance users achieves the optimal balance? Workshops for the COLLABORATE project
6. Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
7. The impact of parent treatment preference and other factors on recruitment: lessons learned from a paediatric epilepsy randomised controlled trial
8. Correction: Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trial
9. Psychometric Properties of an Adapted Stigma Scale and Experiences of Stigma Associated with HIV Pre-exposure Prophylaxis Use Among Men Who have Sex with Men: A Mixed Methods Study
10. Between- and Within-Individual Sociodemographic and Psychological Determinants of PrEP Adherence Among Men Who have Sex with Men Prescribed a Daily PrEP Regimen in Wales
11. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
12. Spanish translation of the ABC taxonomy for medication adherence
13. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
14. The experiences and perspectives of people with gout on urate self‐monitoring
15. Health utilities and costs for neuromyelitis optica spectrum disorder
16. Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
17. Developing feasible person-centred care alternatives to emergency department responses for adults with epilepsy: a discrete choice analysis mixed-methods study.
18. Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study
19. The costs and cost-effectiveness of different service models of palliative care, focusing on end of life care: A rapid review
20. Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluation
21. Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
22. Acceptability of generic versus innovator oral medicines: not only a matter of taste
23. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics
24. A model-based cost-utility analysis of an automated notification system for deteriorating patients on general wards.
25. Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions
26. Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project
27. Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trial
28. Health Utilities and Costs for Motor Neurone Disease
29. The New and Non-Transparent Cancer Drugs Fund
30. Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn’s Disease
31. Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model
32. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease
33. We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.
34. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop
35. We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment
36. Cost effectiveness analysis of treatments for children with uncontrolled asthma symptoms despite taking inhaled corticosteroids
37. A framework for understanding sources of bias in medication adherence research
38. Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus Survey
39. Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
40. Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital
41. A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study
42. What is the effectiveness and cost-effectiveness of interventions in reducing the harms for children and young people who have been exposed to domestic violence or abuse: a rapid review
43. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D
44. New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes
45. Medication adherence research comes of age
46. Value of improving patient safety: health economic considerations for rapid response systems–a rapid review of the literature and expert round table
47. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS
48. Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy
49. A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study (Preprint)
50. Effectiveness of out-patient based acute heart failure care: A pilot randomised controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.